Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • Ambience Group Promoter Shares Insights on 4 decades of Success Business
  • Sikh Community comes up with E-Commerce Platform – www.WSCCKart.com Business
  • Café du Jardin Debuts at Asita Park: L’Opéra and DDA Introduce Delhi’s First Riverside French Outdoor Café Business
  • Mohali’s Top Educational Institute Anee’s School In Collaboration With Radiant Cycles To Organise Wheels Of Good Health Press Release
  • Dr. Namita Mittal Indian-Australian Pathologist Proud finalist of Haut Monde Mrs India worldwide 2024, Season 13 National
  • Avitree World earns global recognition as Next-Gen Mobility and Sports Fitness Innovator Business
  • Vedanta Foundation announced the opening of 100 new livelihood linked skill training centers across India Business
  • Prachi Sharma to Star in Upcoming Kannada Film “Swati Nakshatra” Entertainment

Dr. Yukata Niihara felicitated by Honourable Minister of State, Shri Arun Halder for developing FDA- approved drug ENDARI to fight SCD

Posted on December 16, 2022 By

Dr. Yukata Niihara was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable  Minister of State, Shri Arun Halder

New Delhi, December 16: Dr. Yukata Niihara, e CEO and Chair of Emmaus life sciences Inc. USA, an internationally renowned doctor with over a dozen awards and citations, was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable Minister of State, Shri Arun Halder. This felicitation came as a recognition of Dr. Yuktaka Niihara’s work – the development of an FDA-approved drug ENDARI to fight the scrounge of Sickle cell syndrome worldwide. The event was hosted by Dr.Aditi Govatrikar, a famous Bollywood personality, and Miss World.

Over 20 million people in India suffer from sickle cell disease (SCD) due to genetic reasons. Tribal communities, in particular, are affected at a disproportionately high percentage and suffer exorbitantly because of being underprivileged and lack of resources. To ameliorate their condition and save hundreds of lives, it is vitally necessary to introduce this medication in India.

Dr.Niihara has tied up with an Indian Mumbai-based company, Akash Biomatrix Pvt. Ltd. represented by the undersigned to market and distribute this medicine in India at affordable prices. Emmaus Life sciences Inc of the USA is also seriously exploring setting up a manufacturing and Biotech research facility in India with an initial investment of over USD 300 million.

If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours

Health Tags:Healthcare

Post navigation

Previous Post: What Makes Honey the Most Natural Superfood and What Are Its Benefits?
Next Post: Gali Guleiyan: In the Shadows with Manoj Bajpai

Related Posts

  • First Time Urinary Sphincter Dysfuction Restored Sucessfully with a Synthetic Gel Health
  • Bengaluru to Host Children’s Health Festival and Childhood Obesity Conference on November 15 Health
  • Eye-Q Super Specialty Eye Hospital offers exceptional visual outcomes with iLASIK procedure in Surat Health
  • Knee ACL Tear: From Setback to Comeback Health
  • Laser hair removal for private parts enhances comfort, hygiene: Sakhiya Skin Clinic Health
  • Healing Hospital Chandigarh Named Best Private Hospital by Hon’ble Governor, Launches TB Support Initiative Health

Recent Posts

  • JD Cables Limited Reports Strong H2 FY26 & FY26 Performance
  • ArcelorMittal Nippon Steel India Leads First Industry-Led PM-SETU ITI Transformation
  • Mister Hair Clinic Appoints Dr. Shawn as Head of Department, Bringing International-Standard Hair Transplants to India
  • Intense Technologies Reports FY26 with 11 New Customer Additions Across Banking, Insurance & NBFC Segments
  • Sumeet Industries Limited Reports Resilient FY26 Performance with Total Income Crossing Rs 1,050 Cr & PAT of Rs 27.33 Cr

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • World Population Day: Demographic Trends and the Future of India’s healthcare Health
  • Women Entrepreneur Strikes Again: Shweta Salunkhe Takes Over Civil Aviation Business
  • 2025: A Landmark International Year for Brainobrain Education
  • Sayba Group’s Strategic Redevelopment Projects to Transform Jogeshwari and Bandra West Business
  • Cinépolis India to Be the Official ‘Distribution Partner’ Of Dadasaheb Phalke International Film Festival Awards 2024 Lifestyle
  • Krishna’s Ayurveda, She Care Juice Clinically Proven to Support PCOD Management in 90 Days Health
  • Mutual Funds and Tax Benefits: What Every Investor Should Know Finance
  • “Shuddhi Ayurveda” focuses on the holistic improvement of human health Business

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme